We're probing immune biology to deliver insights and identify your lead candidates
We've leveraged our cutting-edge technologies to build a ground-breaking platform for Immuno-oncology drug discovery. Our collection of high throughput assays allows you to rapidly identify single agents or combinations that effect T cell proliferation and polarization, tumor cell lysis, and natural killer (NK) cell function.
Gene-editing in immune cells for your immuno-oncology project is now even faster than before. Leveraging the latest genome engineering tools, including CRISPR-Cas9, we're able to precisely edit T-cell, B-cell, and monocytes lines.